272 related articles for article (PubMed ID: 31476419)
1. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
van den Ende RPJ; Kerkhof EM; Rigter LS; van Leerdam ME; Peters FP; van Triest B; Staring M; Marijnen CAM; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1151-1159. PubMed ID: 31476419
[TBL] [Abstract][Full Text] [Related]
2. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy.
Kleijnen JJE; van Asselen B; Van den Begin R; Intven M; Burbach JPM; Reerink O; Philippens MEP; de Ridder M; Lagendijk JJW; Raaymakers BW
Acta Oncol; 2019 Feb; 58(2):232-236. PubMed ID: 30444161
[TBL] [Abstract][Full Text] [Related]
3. Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography.
Chong I; Hawkins M; Hansen V; Thomas K; McNair H; O'Neill B; Aitken A; Tait D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e431-8. PubMed ID: 21669504
[TBL] [Abstract][Full Text] [Related]
4. Validating fiducial markers for image-guided radiation therapy for accelerated partial breast irradiation in early-stage breast cancer.
Park CK; Pritz J; Zhang GG; Forster KM; Harris EE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e425-31. PubMed ID: 22284037
[TBL] [Abstract][Full Text] [Related]
5. MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.
van den Ende RPJ; Rigter LS; Kerkhof EM; van Persijn van Meerten EL; Rijkmans EC; Lambregts DMJ; van Triest B; van Leerdam ME; Staring M; Marijnen CAM; van der Heide UA
Radiother Oncol; 2019 Mar; 132():93-99. PubMed ID: 30825976
[TBL] [Abstract][Full Text] [Related]
6. Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared.
van der Horst A; Lens E; Wognum S; de Jong R; van Hooft JE; van Tienhoven G; Bel A
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):641-8. PubMed ID: 24803041
[TBL] [Abstract][Full Text] [Related]
7. Interfractional positional variability of fiducial markers and primary tumors in locally advanced non-small-cell lung cancer during audiovisual biofeedback radiotherapy.
Roman NO; Shepherd W; Mukhopadhyay N; Hugo GD; Weiss E
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1566-72. PubMed ID: 22391105
[TBL] [Abstract][Full Text] [Related]
8. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography.
van der Horst A; Wognum S; Dávila Fajardo R; de Jong R; van Hooft JE; Fockens P; van Tienhoven G; Bel A
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):202-8. PubMed ID: 23790774
[TBL] [Abstract][Full Text] [Related]
9. Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.
Packard M; Gayou O; Gurram K; Weiss B; Thakkar S; Kirichenko A
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):499-506. PubMed ID: 25754023
[TBL] [Abstract][Full Text] [Related]
10. Image-guided radiotherapy for left-sided breast cancer patients: geometrical uncertainty of the heart.
Topolnjak R; Borst GR; Nijkamp J; Sonke JJ
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e647-55. PubMed ID: 22270162
[TBL] [Abstract][Full Text] [Related]
11. Interfraction displacement of primary tumor and involved lymph nodes relative to anatomic landmarks in image guided radiation therapy of locally advanced lung cancer.
Jan N; Balik S; Hugo GD; Mukhopadhyay N; Weiss E
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):210-5. PubMed ID: 24239387
[TBL] [Abstract][Full Text] [Related]
12. Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients.
Schaake EE; Rossi MM; Buikhuisen WA; Burgers JA; Smit AA; Belderbos JS; Sonke JJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):959-66. PubMed ID: 25585787
[TBL] [Abstract][Full Text] [Related]
13. Cervix Motion in 50 Cervical Cancer Patients Assessed by Daily Cone Beam Computed Tomographic Imaging of a New Type of Marker.
Langerak T; Mens JW; Quint S; Bondar L; Heijkoop S; Heijmen B; Hoogeman M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):532-9. PubMed ID: 26460995
[TBL] [Abstract][Full Text] [Related]
14. Image guided radiation therapy for bladder cancer: assessment of bladder motion using implanted fiducial markers.
Biancia CD; Yorke E; Kollmeier MA
Pract Radiat Oncol; 2014; 4(2):108-115. PubMed ID: 24890351
[TBL] [Abstract][Full Text] [Related]
15. Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance.
Qi XS; Hu AY; Lee SP; Lee P; DeMarco J; Li XA; Steinberg ML; Kupelian P; Low D
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):432-9. PubMed ID: 23474111
[TBL] [Abstract][Full Text] [Related]
16. The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.
Thomas M; De Roover R; van der Merwe S; Lambrecht M; Defraene G; Haustermans K
Clin Transl Radiat Oncol; 2021 Jan; 26():8-14. PubMed ID: 33251342
[TBL] [Abstract][Full Text] [Related]
17. Carbon Fiducial Image Guidance Increases the Accuracy of Lumpectomy Cavity Localization in Radiation Therapy for Breast Cancer.
Zhang Y; Mutter RW; Park SS; Hieken TJ; Yan ES; Corbin KS; Brinkmann DH; Pafundi DH
Pract Radiat Oncol; 2019 Jan; 9(1):e14-e21. PubMed ID: 30287358
[TBL] [Abstract][Full Text] [Related]
18. Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy.
Picardi C; Rouzaud M; Kountouri M; Lestrade L; Vallée JP; Caparrotti F; Dubouloz A; Miralbell R; Zilli T
Acta Oncol; 2016 Jul; 55(7):834-8. PubMed ID: 26796870
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: a prospective study.
Mayyas E; Chetty IJ; Chetvertkov M; Wen N; Neicu T; Nurushev T; Ren L; Lu M; Stricker H; Pradhan D; Movsas B; Elshaikh MA
Med Phys; 2013 Apr; 40(4):041707. PubMed ID: 23556877
[TBL] [Abstract][Full Text] [Related]
20. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
